511 related articles for article (PubMed ID: 17600887)
1. Bacteremia caused by Pantoea agglomerans and Enterococcus faecalis in a patient with colon cancer.
Christakis GB; Perlorentzou SP; Aslanidou M; Savva L; Zarkadis IK
J BUON; 2007; 12(2):287-90. PubMed ID: 17600887
[TBL] [Abstract][Full Text] [Related]
2. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy.
Parsonage M; Shah S; Moss P; Thaker H; Meigh R; Balaji A; Elston J; Barlow G
J Antimicrob Chemother; 2010 Feb; 65(2):370-4. PubMed ID: 20022936
[No Abstract] [Full Text] [Related]
5. Pantoea agglomerans septicemia in three newborn infants.
Bergman KA; Arends JP; Schölvinck EH
Pediatr Infect Dis J; 2007 May; 26(5):453-4. PubMed ID: 17468662
[TBL] [Abstract][Full Text] [Related]
6. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
[No Abstract] [Full Text] [Related]
7. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
9. Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
McDonald GR
J Tenn Med Assoc; 1993 Dec; 86(12):527-8. PubMed ID: 8295423
[No Abstract] [Full Text] [Related]
10. Colonic malignancy with recurrent bacteraemia presenting as pyrexia of unknown origin.
Varghese GM; Shenoy M; Subramanian S; Peter S; Mathai D
J Intern Med; 2004 Jun; 255(6):692-3. PubMed ID: 15147536
[No Abstract] [Full Text] [Related]
11. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
[TBL] [Abstract][Full Text] [Related]
12. Six cases of sepsis caused by Pantoea agglomerans in a teaching hospital.
Liberto MC; Matera G; Puccio R; Lo Russo T; Colosimo E; Focà E
New Microbiol; 2009 Jan; 32(1):119-23. PubMed ID: 19382678
[TBL] [Abstract][Full Text] [Related]
13. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
Munoz-Price LS; Lolans K; Quinn JP
Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170
[No Abstract] [Full Text] [Related]
14. [Post-operative bacteremia caused by multidrug-resistant Aerococcus viridans in a patient with gall bladder cancer].
Tekin Koruk S; Bayraktar M; Ozgönül A; Tümer S
Mikrobiyol Bul; 2010 Jan; 44(1):123-6. PubMed ID: 20455408
[TBL] [Abstract][Full Text] [Related]
15. Community-acquired urinary tract infection caused by vancomycin-resistant Enterococcus faecalis clinical isolate.
Aznar E; Buendía B; García-Peñuela E; Escudero E; Alarcón T; López-Brea M
Rev Esp Quimioter; 2004 Sep; 17(3):263-5. PubMed ID: 15619656
[TBL] [Abstract][Full Text] [Related]
16. Blood culture Gram stain and simple clinical categorisation can be used to identify patients at risk for delay in appropriate antibiotic treatment.
Veijola S; Burtonwood M; Stapf J; Kauma H; Kauppila J; Koskela M; Hautala T
Int J Antimicrob Agents; 2008 Dec; 32(6):546-7. PubMed ID: 18789847
[No Abstract] [Full Text] [Related]
17. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases.
Reid KC; Cockerill III FR; Patel R
Clin Infect Dis; 2001 Jun; 32(11):1540-6. PubMed ID: 11340524
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile and strain relatedness of recurrent enterococcal bacteremia.
Cheng AC; Murdoch DR; Harrell LJ; Barth Reller L
Scand J Infect Dis; 2005; 37(9):642-6. PubMed ID: 16126563
[TBL] [Abstract][Full Text] [Related]
19. Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection.
Espinoza R; Kusne S; Pasculle AW; Wada S; Fung J; Rakela J
Clin Transplant; 1997 Aug; 11(4):322-4. PubMed ID: 9267722
[TBL] [Abstract][Full Text] [Related]
20. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
Erlandson KM; Sun J; Iwen PC; Rupp ME
Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
